v3.20.2
Condensed Consolidated Statements of Redeemable Convertible Preferred Stock and Stockholders' Deficit - USD ($)
$ in Thousands
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Income (Loss)
Non-controlling Interest
Redeemable Convertible Preferred Stock
Stockholders' Deficit                  
Cumulative effect of accounting change   $ 23,418       $ 23,418      
Beginning balance (in shares) at Jan. 31, 2019                 131,268,000
Beginning balance at Jan. 31, 2019                 $ 557,912
Increase (Decrease) in Temporary Equity [Roll Forward]                  
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (in shares)                 (131,268,000)
Conversion of redeemable convertible preferred stock to common stock upon initial public offering                 $ (557,912)
Ending balance (in shares) at Jul. 31, 2019                 0
Ending balance at Jul. 31, 2019                 $ 0
Beginning balance (in shares) at Jan. 31, 2019     47,421,000            
Beginning balance at Jan. 31, 2019 $ (487,793)   $ 24 $ 31,211 $ (519,126)   $ 98    
Stockholders' Deficit                  
Common stock issued (in shares)     20,700,000            
Issuance of common stock upon initial public offering, net of underwriting discounts and issuance costs (in shares) 659,218   $ 11 659,207          
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (in shares)     131,268,000            
Conversion of redeemable convertible preferred stock to common stock upon initial public offering 557,912   $ 66 557,846          
Reclassification of redeemable convertible preferred stock warrant liability to additional paid-in capital upon initial public offering 10,559     10,559          
Net exercise of common stock warrants (in shares)     322,000            
Issuance of common stock upon exercise of options (in shares)     4,445,000            
Issuance of common stock upon exercise of options 8,567   $ 2 8,565          
Issuance of common stock related to early exercised options     1,037,356            
Vesting of early exercised stock options 854     854          
Stock-based compensation expense 33,611     33,611          
Capitalized stock-based compensation 245     245          
Net loss (77,866)       (77,866)        
Other comprehensive income (628)           (628)    
Ending balance (in shares) at Jul. 31, 2019     205,193,000            
Ending balance at Jul. 31, 2019 728,097   $ 103 1,302,098 (573,574)   (530)    
Beginning balance (in shares) at Apr. 30, 2019                 131,268,000
Beginning balance at Apr. 30, 2019                 $ 557,912
Increase (Decrease) in Temporary Equity [Roll Forward]                  
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (in shares)                 (131,268,000)
Conversion of redeemable convertible preferred stock to common stock upon initial public offering                 $ (557,912)
Ending balance (in shares) at Jul. 31, 2019                 0
Ending balance at Jul. 31, 2019                 $ 0
Beginning balance (in shares) at Apr. 30, 2019     48,127,000            
Beginning balance at Apr. 30, 2019 (485,177)   $ 24 36,670 (521,685)   (186)    
Stockholders' Deficit                  
Common stock issued (in shares)     20,700,000            
Issuance of common stock upon initial public offering, net of underwriting discounts and issuance costs (in shares) 659,218   $ 11 659,207          
Conversion of redeemable convertible preferred stock to common stock upon initial public offering (in shares)     131,268,000            
Conversion of redeemable convertible preferred stock to common stock upon initial public offering 557,912   $ 66 557,846          
Reclassification of redeemable convertible preferred stock warrant liability to additional paid-in capital upon initial public offering 10,559     10,559          
Net exercise of common stock warrants (in shares)     322,000            
Issuance of common stock upon exercise of options (in shares)     3,739,000            
Issuance of common stock upon exercise of options 7,057   $ 2 7,055          
Issuance of common stock related to early exercised options     1,037,356            
Vesting of early exercised stock options 710     710          
Stock-based compensation expense 29,859     29,859          
Capitalized stock-based compensation 192     192          
Net loss (51,889)       (51,889)        
Other comprehensive income (344)           (344)    
Ending balance (in shares) at Jul. 31, 2019     205,193,000            
Ending balance at Jul. 31, 2019 728,097   $ 103 1,302,098 (573,574)   (530)    
Beginning balance (in shares) at Jan. 31, 2020                 0
Beginning balance at Jan. 31, 2020                 $ 0
Ending balance (in shares) at Jul. 31, 2020                 0
Ending balance at Jul. 31, 2020                 $ 0
Beginning balance (in shares) at Jan. 31, 2020     212,948,000            
Beginning balance at Jan. 31, 2020 742,107                
Beginning balance at Jan. 31, 2020 742,607   $ 106 1,378,479 (637,487)   1,009 $ 500  
Stockholders' Deficit                  
Issuance of common stock upon exercise of options (in shares)     4,689,000            
Issuance of common stock upon exercise of options 16,601   $ 4 16,597          
Issuance of common stock under RSU release (in shares)     992,000            
Issuance of common stock under RSU release 0   $ 0            
Issuance of common stock under employee stock purchase plan (in shares)     565,000            
Issuance of common stock under employee stock purchase plan 17,284     17,284          
Vesting of early exercised stock options 1,722     1,722          
Stock-based compensation expense 61,351     61,351          
Capitalized stock-based compensation 890     890          
Net loss (49,096)       (49,096)        
Non-controlling interest 550             550  
Other comprehensive income 106           106    
Ending balance (in shares) at Jul. 31, 2020     219,194,000            
Ending balance at Jul. 31, 2020 790,965                
Ending balance at Jul. 31, 2020 792,015   $ 110 1,476,323 (686,583)   1,115 1,050  
Beginning balance (in shares) at Apr. 30, 2020                 0
Beginning balance at Apr. 30, 2020                 $ 0
Ending balance (in shares) at Jul. 31, 2020                 0
Ending balance at Jul. 31, 2020                 $ 0
Beginning balance (in shares) at Apr. 30, 2020     215,505,000            
Beginning balance at Apr. 30, 2020 753,153   $ 108 1,409,758 (656,709)   (1,004) 1,000  
Stockholders' Deficit                  
Issuance of common stock upon exercise of options (in shares)     2,633,000            
Issuance of common stock upon exercise of options 10,208   $ 2 10,206          
Issuance of common stock under RSU release (in shares)     491,000            
Issuance of common stock under RSU release 0   $ 0            
Issuance of common stock under employee stock purchase plan (in shares)     565,000            
Issuance of common stock under employee stock purchase plan 17,284     17,284          
Vesting of early exercised stock options 849     849          
Stock-based compensation expense 37,713     37,713          
Capitalized stock-based compensation 513     513          
Net loss (29,874)       (29,874)        
Non-controlling interest 50             50  
Other comprehensive income 2,119           2,119    
Ending balance (in shares) at Jul. 31, 2020     219,194,000            
Ending balance at Jul. 31, 2020 790,965                
Ending balance at Jul. 31, 2020 $ 792,015   $ 110 $ 1,476,323 $ (686,583)   $ 1,115 $ 1,050